Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS often have metabolic issues like insulin resistance and a higher risk of diabetes and abnormal lipid levels.

A higher testosterone/dihydrotestosterone ratio in PCOS patients may indicate worse metabolic health.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

Lifestyle changes improve metabolism and fertility in overweight PCOS patients; anti-obesity drugs show potential but need more research.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Measuring certain hormones can help predict metabolic risk in women with PCOS.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Older age, obesity, hirsutism, and having children increase metabolic risk in women with PCOS.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Blocking a specific enzyme might help treat obesity and diabetes, but more research is needed to ensure it's safe.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Skin issues in PCOS signal hormone problems, and combined treatments improve outcomes.

Skin conditions can signal diabetes and insulin resistance.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

Hair can indicate early signs of metabolic disorders, with issues like protein deficiency stopping hair growth.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Quiescent cells have increased mitochondrial activity and ECM gene expression, but reduced glycolysis.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Female mice with disrupted 5α-reductase 1 had significant metabolic issues, including stress response problems, insulin resistance, liver fat buildup, and obesity.

Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.